Spiering BA et al
The SELECT clinical trial demonstrated conclusively that Semaglutide lowers the risk of severe adverse cardiovascular events such as heart attack and stroke in overweight persons with existing cardiovascular disease
However, due to the potential for linear GBCAs to induce nephrogenic systemic fibrosis (NSF) and tissue deposition issues in patients with impaired renal function, their use in patients with kidney disease is strictly restricted
BENEFITS Sugar Weight Management Supports Metabolism Supports Sugar Metabolism Supports Appetite Supports Regularity Supports Stress Response Supports Hormone Balance Ingredient List Berberine, Niacin (Vitamin B3), Fo-ti Root, Rehmannia root, Amla fruit, Chrysanthemum flower, Asian Ginseng root, Ashwagandha root, Astragalus Hoantchy root, Eleuthero root, Gymnema leaf, Hawthorn berry, Goji berry, Nigella seed, Licorice root, Alpha Lipoic Acid (ALA), Cassia Bark, AdPT (Eleuthero root, Cordyceps mycelia, Rhodiola root, Reishi mycelia, Ashwagandha root, Gynostemma whole), Inositol, Trace Minerals, Bayberry bark, EDS (Amylase, Protease, Lipase, Cellulase), Chromium Nicotinate Reviews: William M